The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Multiple Myeloma: Clinical Review and Diagnostic Imaging
Abstract
Multiple myeloma (MM) is a malignant clonal neoplasm of plasma cells of B-lymphocyte origin that commonly results in overproduction of large amounts of monoclonal immunoglobulins. Important advances in the therapeutic management of this disease in the past decade have resulted in higher rates of durable complete remission, prolonged event-free survival, and improved overall survival. Clearer understanding of the effects of abnormal plasma cells on bone has led to therapeutic approaches that help prevent vertebral body fractures. Current imaging technologies and, in particular, survey marrow studies with magnetic resonance (MR) imaging have improved detection of the extent and location of disease in MM patients. In newly diagnosed cases, MR surveys of the axial skeleton accurately demonstrate the extent of disease-diffuse or focal involvement-and the presence of associated compression fractures and cord compression. After treatment, MR images show the effects of treatment and the presence of residual disease. Multiple sites of focal bone lesions detected on MR studies allow a more appropriate choice of biopsy site than the usual random iliac marrow biopsy. Use of MR to determine biopsy sites and computed tomographic guidance for biopsy performance have increased the safety and accuracy of sampling. These biopsies have resulted in increased identification of cytogenetic abnormalities, particularly the presence of chromosome 13 deletion, which is a grave prognostic indicator in MM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
Vogler, J. B., & Murphy, W. A. (1988) · Radiology · doi:10.1148/radiology.168.3.3043546 · Cited by 732
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Cell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms, D. R., Chiu, M. L., Budding, M., Kronauge, J. F., Kramer, R. A., & Croop, J. M. (1993) · PubMed · Cited by 512
Ricci, C., Cova, M., Kang, Y. S., Yang, A., Rahmouni, A., Scott, W. W., & Zerhouni, E. A. (1990) · Radiology · doi:10.1148/radiology.177.1.2399343 · Cited by 417
Solitary plasmacytoma of bone and asymptomatic multiple myeloma
Dimopoulos, M. A., Moulopoulos, L. A., Maniatis, A., & Alexanian, R. (2000) · Blood · doi:10.1182/blood.v96.6.2037 · Cited by 397
Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Self-citationCytogenetic findings in 200 patients with multiple myeloma
Sawyer, J. R., Waldron, J. A., Jagannath, S., & Barlogie, B. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00284-i · Cited by 343
Self-citationRed and yellow marrow in the femur: age-related changes in appearance at MR imaging.
Moore, S. G., & Dawson, K. L. (1990) · Radiology · doi:10.1148/radiology.175.1.2315484 · Cited by 332
Plasma cell myeloma--new biological insights and advances in therapy
Barlogie, B., Epstein, J., Selvanayagam, P., & Alexanian, R. (1989) · Blood · doi:10.1182/blood.v73.4.865.865 · Cited by 325
Self-citationGreipp, P., Lust, J., O'Fallon, W., Katzmann, J., Witzig, T., & Kyle, R. (1993) · Blood · doi:10.1182/blood.v81.12.3382.3382 · Cited by 312
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system
Bataille, R., Boccadoro, M., Klein, B., Durie, B., & Pileri, A. (1992) · Blood · doi:10.1182/blood.v80.3.733.733 · Cited by 294
In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates
Aparicio, A., Gardner, A., Tu, Y., Savage, A., Berenson, J., & Lichtenstein, A. (1998) · Leukemia · doi:10.1038/sj.leu.2400892 · Cited by 259
Magnetic resonance imaging in the staging of solitary plasmacytoma of bone.
Moulopoulos, L. A., Dimopoulos, M. A., Weber, D., Fuller, L., Libshitz, H. I., & Alexanian, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1311 · Cited by 223
Mirowitz, S. A., Apicella, P., Reinus, W. R., & Hammerman, A. M. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.1.8273669 · Cited by 210
Dimopoulos, M. A., Barlogie, B., Smith, T. L., & Alexanian, R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-931 · Cited by 208
Self-citationMagnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies
Moulopoulos, L. A., & Dimopoulos, M. A. (1997) · Blood · doi:10.1182/blood.v90.6.2127 · Cited by 202
Durie, B., Stock-Novack, D., Salmon, S., Finley, P., Beckord, J., Crowley, J., & Coltman, C. (1990) · Blood · doi:10.1182/blood.v75.4.823.823 · Cited by 188
Moulopoulos, L. A., Dimopoulos, M. A., Smith, T. L., Weber, D. M., Delasalle, K. B., Libshitz, H. I., & Alexanian, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.251 · Cited by 185
Initial results in the assessment of multiple myeloma using 18F-FDG PET
Schirrmeister, H., Bommer, M., Buck, A., Müller, S., Messer, P., Bunjes, D., Döhner, H., Bergmann, L., & Reske, S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0711-3 · Cited by 174
Tricot, G., Sawyer, J. R., Jagannath, S., Desikan, K. R., Siegel, D., Naucke, S., Mattox, S., Bracy, D., Munshi, N., & Barlogie, B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2659 · Cited by 172
Self-citationFassas, A. B. ‐., Muwalla, F., Berryman, T., Benramdane, R., Joseph, L., Anaissie, E., Sethi, R., Desikan, R., Siegel, D., Badros, A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03401.x · Cited by 167
Self-citationDel Vecchio, S., Ciarmiello, A., Potena, M. I., Carriero, M. V., Mainolfi, C., Botti, G., Thomas, R., Cerra, M., D'Aiuto, G., Tsuruo, T., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf02439547 · Cited by 163
Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey
Lecouvet, F. E., Malghem, J., Michaux, L., Maldague, B., Ferrant, A., Michaux, J., & Vande Berg, B. C. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01529.x · Cited by 159
Risk of disease progression in asymptomatic multiple myeloma
Dimopoulos, M. A., Moulopoulos, A., Smith, T., Delasalle, K. B., & Alexanian, R. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90120-e · Cited by 158
Diagnostic Criteria of Multiple Myeloma
Kyle, R. A. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30348-4 · Cited by 156
New insights into role of microenvironment in multiple myeloma
Tricot, G. J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)00019-2 · Cited by 149
Cytokine Network in Human Multiple Myeloma
Klein, B., & Bataille, R. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30344-7 · Cited by 145
Localized and indolent myeloma
Alexanian, R. (1980) · Blood · doi:10.1182/blood.v56.3.521.521 · Cited by 141
The growth fraction of human myeloma cells
Drewinko, B., Alexanian, R., Boyer, H., Barlogie, B., & Rubinow, S. (1981) · Blood · doi:10.1182/blood.v57.2.333.333 · Cited by 141
Self-citationNoncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes.
Piwnica-Worms, D. R., & Holman, B. L. (1990) · PubMed · Cited by 140
Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet, F. E., Berg, B. C. V., Michaux, L., Malghem, J. J., Maldague, B., Jamart, J., Ferrant, A., & Michaux, J. (1998) · Radiology · doi:10.1148/radiology.209.3.9844655 · Cited by 138
Prognostic features of asymptomatic multiple myeloma
Weber, D. M., Dimopoulos, M. A., Moulopoulos, L. A., Delasalle, K. B., Smith, T., & Alexanian, R. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1122939.x · Cited by 122
Multiple Myeloma in Patients Younger Than 30 Years: Report of 10 Cases and Review of the Literature
Bladé, J. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440120125014 · Cited by 121
Piwnica-Worms, D., Rao, V. V., Kronauge, J. F., & Croop, J. M. (1995) · Biochemistry · doi:10.1021/bi00038a015 · Cited by 113
Solitary plasmacytoma of bone and asymptomatic multiple myeloma
Dimopoulos, M. A., Moulopoulos, L. A., Maniatis, A. G., & Alexanian, R. (2000) · Blood · doi:10.1182/blood.v96.6.2037.h8002037_2037_2044 · Cited by 70
Magnetic resonance imaging patterns in patients with multiple myeloma
KUSUMOTO, S., Jinnai, I., Itoh, K., Kawai, N., Sakata, T., Matsuda, A., Tominaga, K., MUROHASHI, I., Bessho, M., Harashima, K., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4213236.x · Cited by 64
Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-up
Dimopoulos, M. A. (2000) · Acta Oncologica · doi:10.1080/028418600750063578 · Cited by 60
Evaluation of diagnostic criteria in polycythemia vera
Pearson, T. C. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90136-2 · Cited by 58
High-dose therapy and innovative approaches to treatment of multiple myeloma
Barlogie, B. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90091-5 · Cited by 37
Self-citationPathophysiology and Management of Bone Disease in Multiple Myeloma
Niesvizky, R., & Warrell, R. P. (1997) · Cancer Investigation · doi:10.3109/07357909709018921 · Cited by 10
Cited by
Martinez-Möller, A., Souvatzoglou, M., Delso, G., Bundschuh, R. A., Chefd'hotel, C., Ziegler, S. I., Navab, N., Schwaiger, M., & Nekolla, S. G. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054726 · Cited by 712
Bartel, T. B., Haessler, J., Brown, T. L. Y., Shaughnessy, J. D., van Rhee, F., Anaissie, E., Alpe, T., Angtuaco, E., Walker, R., Epstein, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213280 · Cited by 518
Self-citationMagnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications
Walker, R., Barlogie, B., Haessler, J., Tricot, G., Anaissie, E., Shaughnessy, J. D., Epstein, J., van Hemert, R., Erdem, E., Hoering, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5803 · Cited by 417
Self-citationZamagni, E., Nanni, C., Patriarca, F., Englaro, E., Castellucci, P., Geatti, O., Tosi, P., Tacchetti, P., Cangini, D., Perrone, G., et al. (2007) · Haematologica · doi:10.3324/haematol.10554 · Cited by 354
Metadata
- Authors
- Angtuaco, E. J. C., Fassas, A. B. T., Walker, R., Sethi, R., & Barlogie, B.
- Venue
- Radiology
- Published
- 2004-04
- Volume
- 231
- Issue
- 1
- Pages
- 11-23
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2099218964
- Cited by
- 299
- References
- 46
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.